SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
Merck Sharp & Dohme LLC
Karyopharm Therapeutics Inc
Poseida Therapeutics, Inc.
Virginia Commonwealth University
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
Ipsen
Memorial Sloan Kettering Cancer Center
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Insel Gruppe AG, University Hospital Bern
City of Hope Medical Center
Pell Bio-Med Technology Co., Ltd.
ImmunityBio, Inc.
Ipsen
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Sunnybrook Health Sciences Centre
City of Hope Medical Center
Celgene
Atara Biotherapeutics
Centre Hospitalier Universitaire, Amiens
Roswell Park Cancer Institute
Rush University Medical Center
Novartis
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
University of South Florida
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute
University of Chicago
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences